[1] Mayo-Smith WW, Boland GW, Noto RB, et al. State-of-the-art adrenal imaging[J]. Radiographics, 2001, 21(4):995-1012. DOI:10.1148/radiographics.21.4.g01jl21995.
[2] Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer[J]. J Nucl Med, 2004, 45(12):2058-2062.
[3] Vikram R, Yeung HD, Macapinlac HA, et al. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer[J]. AJR Am J Roentgenol, 2008, 191(5):1545-1551. DOI:10.2214/AJR.07.3447.
[4] Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT:prevalence of adrenal disease in 1, 049 consecutive adrenal masses in patients with no known malignancy[J]. AJR Am J Roentgenol, 2008, 190(5):1163-1168. DOI:10.2214/AJR.07.2799.
[5] 曲倩倩, 董印, 韩雪, 等.扩散加权成像对肾上腺肿瘤的鉴别诊断价值[J].医学影像学杂志, 2015, 25(3):492-495.
Qu QQ, Dong Y, Han X, et al. The use of diffusion weighted imaging in the differential diagnosis of adrenal tumor[J]. J Med Imaging, 2015, 25(3):492-495.
[6] 谢君伟, 左庆国, 王都.多层螺旋CT与MRI在嗜铬细胞瘤诊断中的价值[J].国际放射医学核医学杂志, 2011, 35(4):245-248. DOI:10.3760/cma.j.issn.1673-4114.2011.04.013.
Xie JW, Zuo QG, Wang D. The value of CT and MRI in diagnosis of pheochromocytoma[J]. Int J Radiat Med Nucl Med, 2011, 35(4):245-248.  doi: 10.3760/cma.j.issn.1673-4114.2011.04.013
[7] Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT:an analysis of the CT literature[J]. AJR Am J Roentgenol, 1998, 171(1):201-204. DOI:10.2214/ajr.171. 1.9648789.
[8] Mansmann G, Lau J, Balk E, et al. The clinically in apparent adrenal mass:update in diagnosis and management[J]. Endocr Rev, 2004, 25(2):309-340. DOI:10.1210/er.2002-0031.
[9] Brady MJ, Thomas J, Wong TZ, et al. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer:a proposal for an efficient diagnostic algorithm[J]. Radiology, 2009, 250(2):523-530. DOI:10.1148/radiol.2502080219.
[10] Wu Q, Luo W, Zhao Y, et al. The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer:a PRISMA-compliant meta-analysis[J]. Nucl Med Commun, 2017, 38(12):1117-1124. DOI:10.1097/MNM.0000000000000757.
[11] Metser U, Miller E, Lerman H, et al. 18F-FDG PET/CT in the evaluation of adrenal masses[J]. J Nucl Med, 2006, 47(1):32-37.
[12] Cho AR, Lim I, Na II, et al. Evaluation of Adrenal Masses in Lung Cancer Patients Using 18F-FDG PET/CT[J]. Nucl Med Mol Imaging, 2011, 45(1):52-58. DOI:10.1007/s13139-010-0064-6.
[13]

Kim JY, Kim SH, Lee HJ, et al. Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement[J/OL]. Br J Radiol, 2013, 86(1028): 20130190[2018-04-01]. https: //www. birpublications. org/doi/pdf/10. 1259/bjr. 20130190. DOI: 10.1259/bjr.20130190.

[14] Kim BS, Lee JD, Kang WJ. Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT[J].Ann Nucl Med, 2015, 29(3):276-283. DOI:10.1007/s12149-014-0937-3.
[15] Kunikowska J, Matyskiel R, Toutounchi S, et al. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?[J]. Eur J Nucl Med Mol Imaging, 2014, 41(12):2273-2280. DOI:10.1007/s00259-014-2844-1.
[16]

Launay N, Silvera S, Tenenbaum F, et al. Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses[J/OL]. Int J Endocrinol, 2015, 2015: 213875[2018-04-01]. https: //www. ncbi. nlm. nih. gov/pmc/articles/PMC4333271/pdf/IJE2015-213875. pdf. DOI: 10.1155/2015/213875.